key: cord-0935606-em608m8s
authors: Sciagrà, Roberto; Rubino, Federica; Malandrino, Danilo; Bernardeschi, Nicoletta; Pignone, Alberto Moggi; Berni, Andrea
title: Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism
date: 2020-05-26
journal: Eur J Nucl Med Mol Imaging
DOI: 10.1007/s00259-020-04868-x
sha: 52116f126c73815fbfb05f3d0a9526eb302f3691
doc_id: 935606
cord_uid: em608m8s

nan

PET/CT identifies FDG uptake, but presently there is no role for Nuclear Medicine in COVID-19 [1, 2] . However, thrombophilia is reported, and pulmonary emboli described [3] [4] [5] . In an 85-year-old man with dilated cardiomyopathy referred to the hospital because of dyspnea and cough, CT revealed bilateral pleural effusion with lower lobe ground glass opacities, but nasopharyngeal swab was negative for COVID-19, and hemoptysis plus persistence of severe hypoxemia with hypocapnia raised the suspicion of pulmonary embolism. Owing to elevated creatinine level, pulmonary perfusion SPECT was preferred, and initially reported as abnormal, but not diagnostic of acute embolism, because of uptake defects mainly coinciding with parenchymal anomalies. Subsequently, a second swab revealed infection by SARS-CoV-2. The patient was transferred to a COVID Unit, developed respiratory failure and fever (38.5°), and died 3 days later; last D-dimer was 1299 ng/mL and LDH 350 U/L. The lung scan was then reviewed after fusion with last CT. Figures 1 and 2 show the presence in the perfusion SPECT images (left panel, upper row: transaxial and coronal slices; lower row: sagittal slice and three-dimensional rendering) of small peripheral uptake defects (white arrows and arrowhead). In the corresponding CT images (right panel: same disposition, scout image in the lower right corner), the red arrows point to the parenchymal areas corresponding to the perfusion defects, which appear normally ventilated. These findings suggest that lung perfusion SPECT could identify perfusion abnormalities in early phase of COVID-19. Further studies are desirable to establish whether this could be helpful for these patients.

This article is part of the Topical Collection on Infection and inflammation.

* Roberto Sciagrà roberto.sciagra@unifi.it

Conflict of interest The authors declare that they have no conflict of interest.

Ethical approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent According to our current Institutional procedure, the patient signature on the Exam Authorization Form includes the consent to the use of anonymized data for research purposes. 

F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases

PET imaging of COVID-19: the target and the number

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

Pulmonary embolism in patients with COVID-19: time to change the paradigm of computed tomography

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations